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ABSTRACT
Cancer patients often experience multiple symptoms,
and those symptoms can independently predict changes
in patient function, treatment failures, and post-thera-
peutic outcomes. Symptom clusters are defined as two
or more concurrent symptoms that are related and may
or may not have a common cause. The purpose of the
present study was to review, in cancer patients, com-
mon symptom clusters and their predictors.
Using MEDLINE, EMBASE, Cochrane Central, and
CINAHL, we conducted a literature search on symp-
tom clusters in cancer patients. Studies that investi-
gated predetermined clusters were not included. We
identified seven individual studies and one group of
five studies validating the M.D. Anderson Symptom
Inventory. These studies had been published between
1997 and 2006. Two of the seven individual studies
and the group of five studies that had validated the
M.D. Anderson Symptom Inventory included patients
with any cancer type; three studies included breast
cancer patients only; and two studies included lung
cancer patients only.
A gastrointestinal cluster consisting of nausea and
vomiting was the single cluster common to two of the
studies. The severity of this cluster increased when
patients were treated with chemotherapy. No common
clusters were found in the lung and breast cancer pa-
tient populations. However, breast cancer patients
experienced more symptom cluster involvement while
undergoing chemotherapy. We noted methodology
disparities among the papers with regard to assess-
ment tools used, statistical analyses, and populations.
Research on symptom clusters is still in an early
stage. Multiple symptoms clearly affect prognosis,
quality of life, and functional status. The study of
symptom clusters is important for its implications
regarding patient management, and a consensus on
appropriate research methodology is vital.
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1. INTRODUCTION
Cancer patients often experience multiple symptoms,
and symptoms seldom occur in isolation in patients
with advanced cancer. Cancer patients have been re-
ported to experience an average of 11–13 concurrent
symptoms 1,2. Symptoms may be a result of the dis-
ease itself or of the associated treatment. They may
considerably affect the patient’s sense of wellbeing
and his or her physical and social functions. How-
ever, most clinical studies in symptom research have
focused largely on the treatment of individual symp-
toms. This focus has undoubtedly led to some ad-
vances in the understanding of particular symptoms,
but patients seldom present with a single symptom—
which may perhaps explain why treating one symp-
tom may not necessarily improve quality of life.
The co-occurring symptoms that cancer patients
often experience may or may not be interrelated. Al-
though a continuing focus on single-symptom re-
search is crucial, it is equally important that symptom
management research begin to evaluate multiple
symptoms in cross-sectional and longitudinal study
designs. In addition, research needs to more closely
examine the relationships between multiple symp-
toms, specific interventions, and patient outcomes.
The occurrence of multiple symptoms indepen-
dently predicts changes in patient function, treatment
failures, and post-therapeutic outcomes. Recently,
systematic attention has turned to the occurrence of
multiple symptoms in cancer patients, with reports
that “symptom complexes” or “clusters” may occur.
Dodd and colleagues were among the first to coin
the term “symptom clusters” in their work with pain,
fatigue, and sleep disturbances 3. Their definition of
symptom clusters specifies the presence of 3 or more
concurrent symptoms that are related and that may
or may not have a common cause. They did not de-
fine the strength of the cluster relationship, however.
Another paper described symptom clusters as 2 or
more symptoms that are related, that occur together,
that form a stable group, and that are relatively inde-
pendent of other clusters 4.
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Although the definition of a symptom cluster has
not yet been fully elucidated, the presence of mul-
tiple co-occurring symptoms can have an adverse
effect on patient outcome and may have a synergistic
effect as a predictor of patient morbidity. The objec-
tive of the present review was to report patterns of
symptom clusters found in cancer patients to date.
The specific research questions were these:
• Do certain symptom clusters commonly occur in
oncology patients?
• Do predictors of symptom clusters exist?
2. MATERIALS AND METHODS
In October 2006, we conducted a literature search in
four databases (MEDLINE, EMBASE, Cochrane Central,
and CINAHL) to identify all studies on symptoms clus-
ters in cancer patients. The search was unrestricted
as to date, but restricted to publications in English.
The subject headings “symptom cluster,” “multiple
symptoms,” “symptom constellation,” “symptom
combinations,” or “co-occurrence of symptoms” were
combined with “cancer” or “oncol-.”
The search identified a total of 223 articles. Cita-
tions and articles listed as “relevant” in PubMed were
also considered for review. All abstracts, full-text
publications, letters, and editorials were reviewed.
Only studies that tested statistically for a symptom
cluster within a set of symptoms were included. Ar-
ticles that reported predetermined symptom clusters
were excluded from this review.
3. RESULTS
Seven individual studies and one group of five stud-
ies validating the M.D. Anderson Symptom Inven-
tory (MDASI) found evidence of symptom clusters in
cancer patients 5–16. The publication dates ranged from
1997 to 2006. Identification of symptom clusters was
the primary endpoint in five of the seven studies, but
the study populations varied. Two individual studies
and the group of five studies that validated the MDASI
included patients with any type of cancer 5–11; three
studies included only breast cancer patients (14-16); and
two studies included only lung cancer patients (12,13).
3.1 Common Clusters in Cancer Patients
Identifying symptom clusters in patients with any
cancer type was the primary endpoint for two of the
papers 5,6 discussed in this section.
Walsh and Rybicki 5 found 7 symptom clusters in
922 patients with advanced cancer. Their 38-symp-
tom checklist graded each symptom as absent, mild,
moderate, or severe. Cluster analysis using an
agglomerative hierarchical method with linking aver-
age was used to identify the clusters in this 1-centre
study. Only 25 symptoms with >15% prevalence were
selected for analysis, and a correlation of ³0.68 was
used to define the final clusters (fatigue/anorexia/
cachexia, neuro-psychological, upper gastrointestinal,
nausea/vomiting, aerodigestive, debility, and pain).
Table I lists the symptoms that belong in each cluster.
Chen and Tseng reported 3 symptom clusters in
their study of 151 cancer patients in a Taiwan cen-
tre 6. Participants were asked to complete the 13-item
MDASI and the 14-item Hospital Anxiety and Depres-
sion Scale. This cross-sectional study used principal
component analysis with oblique rotation to factor
the selected symptoms. The 3 identified clusters (sick-
ness, gastrointestinal, emotional) were found using
the foregoing statistical technique, which explained
55% of the variance (Table I). Mean scores for the
sickness syndrome were higher when patients re-
ported pain or were advanced in their disease. Pa-
tients undergoing chemotherapy treatment
experienced higher mean scores for the gastrointes-
tinal cluster.
During validation of the English, Japanese, Chi-
nese, and Filipino versions of the MDASI, the authors
found 2 consistent symptom clusters in all four trans-
lations of the assessment tool 7–10. The sample popu-
lations ranged in number from 206 to 527 patients,
and all four studies used the principal axis factor
analysis technique with oblimin rotation for cluster
determination. The first cluster was labelled general
symptom severity (comprising pain, fatigue, disturbed
sleep, emotional distress, shortness of breath, drowsi-
ness, dry mouth, sadness, difficulty remembering, and
numbness or tingling). The second cluster was la-
belled gastrointestinal (comprising nausea and vom-
iting). In three of the validation studies (English,
Chinese, Filipino), patients receiving chemotherapy
had significantly higher mean scores in the gastro-
intestinal cluster (p < 0.05, p < 0.002, p < 0.005 re-
spectively). The Japanese version did not report
chemotherapy as a factor influencing the severity of
symptoms within the gastrointestinal cluster.
Interestingly, the Russian validation of the MDASI
found 3 clusters: general, treatment-related, and af-
fective 11. There was no evidence of the gastrointesti-
nal cluster. However, patients receiving chemotherapy
experienced greater symptom prevalence.
The gastrointestinal cluster (labelled nausea/vom-
iting in the paper by Walsh and Rybicki) is the single
cluster that is common to the reported studies. This
cluster includes 2 symptoms: nausea and vomiting.
When patients were treated with chemotherapy, the
severity of the symptoms in the gastrointestinal clus-
ter increased, as reported by Chen and Tseng and the
authors of the English, Chinese, and Filipino valida-
tions of the MDASI.
Among the seven papers discussed here, no other
common symptom clusters emerged. Notable are the
differences in the methodology of the studies. Chen
and Tseng and the authors of the MDASI validations
used the same statistical method and assessment tool,S
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TABLE I Review of symptom clusters in cancer patients 5–11
Reference Patients Cancer site Statistical analysis Symptom cluster Associated symptoms Assessment
(n) method tools
Walsh and Rybicki, 922 No specific site Cluster analysis Fatigue/anorexia–cachexia Fatigue, weakness, anorexia, lack of 38-item symptom
2006 5 (agglomerative hierarchical energy, dry mouth, early satiety, checklist
with average linkage) weight loss, taste change
Neuro-psychological Sleep, depression, anxiety
Upper GI Dizziness, dyspepsia, belching, bloating
Nausea/vomiting Nausea/vomiting
Aerodigestive Dyspnea, cough, hoarseness, dysphagia
Debility Edema, confusion
Pain Pain constipation
Chen and Tseng, 151 No specific site Factor analysis Sickness Fatigue, sleep disturbance, lack of 13-item MD
2006 6 (23 outpatients) (principal-axis factoring appetite, drowsiness  Anderson Symptom
(128 inpatients) with oblique rotation) Gastrointestinal Nausea, vomiting Inventory, 14-item
Emotional Distress and sadness Hospital Anxiety Items
and Depression scale
Wang et al., 249 No specific site Factor analysis General Pain, fatigue, disturbed sleep, emotional MD Anderson
2004 8 (principal axis factoring distress, shortness of breath, drowsiness, Symptom Inventory
(Chinese validation) with direct oblimin rotation) dry mouth, sadness, difficulty
remembering, numbness or tingling
Gastrointestinal Nausea, vomiting
Cleeland et al., 527 No specific site Factor analysis General Pain, fatigue, disturbed sleep, emotional MD Anderson
2000 10 (principal axis factoring distress, shortness of breath, drowsiness, Symptom Inventory
(English validation) with direct oblimin rotation) dry mouth, sadness, difficulty
remembering, numbness or tingling
Gastrointestinal Nausea, vomiting
Wang et al., 206 No specific site Factor analysis General Pain, fatigue, disturbed sleep, emotional MD Anderson
2006 7 (principal axis factoring distress, shortness of breath, drowsiness, Symptom Inventory
(Filipino validation) with direct oblimin rotation) dry mouth, sadness, difficulty
remembering, numbness or tingling
Gastrointestinal Nausea, vomiting
Okuyama et al., 252 No specific site Factor analysis General Pain, fatigue, disturbed sleep, emotional MD Anderson
2003 9 (principal axis factoring distress, shortness of breath, drowsiness, Symptom Inventory
(Japanese validation) with direct oblimin rotation) dry mouth, sadness, difficulty
remembering, numbness or tingling
Gastrointestinal Nausea, vomiting
Ivanova et al., 226 No specific site Factor analysis General Pain, fatigue, disturbed sleep, drowsiness, MD Anderson
2005 11 (principal axis factoring loss of appetite Symptom Inventory
(Russian validation) with direct oblimin rotation) Treatment-related Nausea, vomiting, shortness of breath,
numbness, difficulty remembering,
dry mouth
Affective Emotional distress, sadnessFAN et al.
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but Walsh and Rybicki adopted a different statistical
method and assessment tools.
3.2 Clusters in Lung Cancer Patients
Two studies included only lung cancer patients. Sarna
and Brecht 12 were among the first authors to cluster
symptoms. The primary endpoint of their study was
to explore the structure of symptom distress in women
with advanced lung cancer. They used the Symptom
Distress Inventory to survey 60 women with advanced
lung cancer who were receiving palliative treatment.
To identify symptom combinations, the authors used
principal component analysis with varimax rotation.
Their results showed symptoms clustered in 4 groups
explaining 63.3% of variance. These clusters were
emotional and physical suffering, gastrointestinal dis-
tress, respiratory distress, and malaise. Table II lists
the symptoms within each cluster.
Gift et al. 13 surveyed 220 newly diagnosed pa-
tients with lung cancer. These authors used the 37-item
Physical Symptom Experience tool with a 3-point
system to rate symptom severity. Because of missing
responses, only 32 of the 37 symptoms were included
in the analysis. Factor analysis was used to find and
extract clusters, and only 1 cluster was found for which
all symptoms were consistently correlated (Cronbach
a = 0.73). The symptoms in that cluster were nausea,
fatigue, weakness, appetite loss, weight loss, altered
taste, and vomiting. Patients receiving chemotherapy
experienced more symptoms in that cluster.
Because Gift et al. reported only 1 large symp-
tom cluster, extracting a similar cluster from the symp-
tom clusters found by Sarna and Brecht is difficult.
Again, the differences in the methodologies used are
notable. The limited research conducted thus far into
symptom clusters in lung cancer patients makes it
impossible to further explore common symptom clus-
ters in this population.
3.3 Clusters in Breast Cancer Patients
Three studies included breast cancer patients only, but
each study used different subpopulations. Bender
et al. 14 explored differences in symptom clusters
across 3 disease stages: early stage (n = 40, group 1),
stage I/II/III (n = 88, group 2), and stage  IV (n = 26,
group 3). All patients completed multiple assessment
tools including the Profile of Mood States, the Symp-
tom Checklist, a daily symptom diary, the Menopausal
Quality of Life Scale, and the Functional Assessment
of Cancer Therapy Anemia/Fatigue scale. Using hi-
erarchical cluster analysis in this exploratory second-
ary analysis, 4 clusters were found in group 1, 3 in
group 2, and 2 in group 3. The 4 clusters seen in
group 1 were fatigue, perceived cognitive impairment,
mood problems, and other. The 3 clusters in group 2
were fatigue, perceived cognitive impairment, and
mood problems. Group 3 patients experienced only
the fatigue and mood problems clusters. Based on the
definition that symptom clusters involve 2 or more
symptoms, the fatigue and mood problems symptom
clusters were found to be common across all 3 groups.
Table III lists the symptoms in each cluster.
In a study that aimed to explore the occurrence
and frequency of menopausal symptoms, Glaus
et al. 15 found 1 symptom cluster in breast cancer
patients (n = 373; 301 early-stage, and 72 late-stage)
actively receiving hormone treatment. The Checklist
for Patients with Endocrine Therapy and the Interna-
tional Breast Cancer Study Group Linear Analogue
Scales for patients with endocrine treatment were
used. The cluster analysis grouped symptoms using
the agglomerative hierarchical method. The identi-
fied symptom cluster was named menopausal (com-
prising hot flashes/sweats, tiredness/fatigue, weight
gain, vaginal dryness, and decreased sexual interest).
The symptoms were found to be more prevalent in
early-stage breast cancer patients.
Ridner 16 compared quality of life and symptoms
in breast cancer patients with and without lymphe-
dema. Each group accrued 64 patients who completed
a 52-item symptom checklist developed by the au-
thors, the 11-item Iowa 11 by 3 short-form Center
for Epidemiologic Studies of Depression scale (to
measure depressive symptoms), and the 37-item Pro-
file of Mood States–Short Form to measure mood
disturbances. Using analysis of covariance, a symp-
TABLE II Review of symptom clusters in lung cancer patients 12,13
Reference Patients Cancer site Statistical Symptom cluster Associated symptoms Assessment
(n) analysis method tools
Sarna and Brecht, 60 Advanced lung Factor analysis Emotional/physical Pain frequency, pain severity, Symptom
1997 12 (women) (principal components suffering bowel, appearance, outlook  Distress
with varimax rotation) Gastrointestinal Nausea frequency, nausea  Inventory
distress severity, appetite
Respiratory distress Insomnia, breathing, cough
Malaise Fatigue, concentration
Gift et al., 220 Lung Factor analysis Cluster 1 Fatigue, weakness, nausea, 37-item Physical
2004 13 vomiting, loss of appetite, Symptom
weight loss, altered taste  Experience toolSYMPTOM CLUSTERS IN CANCER PATIENTS
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tom cluster was found in women who had previously
been treated for lymphedema. The cluster consists of
alteration in limb sensation, loss of confidence in
body, decreased physical activity, fatigue, and psy-
chological distress.
In these studies, breast cancer patients experience
common symptoms, but no common symptom clus-
ters. Because each study examined different patient
populations and used different assessment tools spe-
cific to the population under study, identification of
common clusters would not be expected.
3.4 Predictors for Symptom Clusters
In the reported studies, a pattern in the occurrence of
symptom clusters is emerging. Patients undergoing
chemotherapy treatment and patients in the early
stages of breast cancer tend to experience more symp-
tom cluster involvement.
Chen and Tseng and the MDASI validation authors
found that chemotherapy patients experience nausea
and vomiting (symptoms in the reported gastrointes-
tinal symptom cluster) at higher intensity levels. Simi-
larly Gift et al. found that lung cancer patients expe-
rience a greater number of symptoms when treated
with chemotherapy. These findings are consistent
with the literature and entirely unsurprising, because
nausea and vomiting are reported as two of the most
distressing symptoms experienced by chemotherapy
patients 17,18.
Bender et al. found more symptom clusters in
early-stage breast cancer patients, and Glaus et al.
found evidence that early-stage breast cancer patients
are more inclined to experience symptoms in the
menopausal symptom cluster. These findings must
be interpreted cautiously because of confounding fac-
tors. For example, the bodily aches and pain experi-
enced by patients in Bender et al.’s early-stage group
may have been caused by recent surgeries. And the
discrepancy in the sample sizes of the early- and late-
stage patients in the study by Glaus et al. may have
contributed to the results noted by the authors.
These findings are preliminary because of the lack
of studies on symptom clusters completed to date and
TABLE III Review of symptom clusters in breast cancer patients 14–16
Reference Patients Cancer Statistical Symptom cluster Associated symptoms Assessment
(n) site analysis method tools
Bender et al., 40 Early stage Breast Hierarchical Fatigue Fatigue, lacking energy, Profile of Mood States,
2005 14 cluster analysis weakness Symptom Checklist, daily
Perceived cognitive Memory problems, symptom diary,
impairment concentration loss Menopausal Quality
Mood problems Anxiety, depression of Life scale,
Other Difficulty sleeping aching Functional Assessment
muscles, backaches of Cancer Therapy
88 Stage I/II/III Fatigue Fatigue, lacking energy, Anemia/Fatigue scale
weakness
Perceived cognitive Memory problems,
 impairment concentration loss
Mood problems Anxiety, depression
26 Stage IV Fatigue Fatigue, lacking energy,
weakness
Mood problems Anxiety, depression
TOTAL: 154 Common clusters: Fatigue
Mood problems
Glaus et al., 373 Breast Cluster analysis Menopausal Hot flashes/sweats, Clinical Checklist for
2006 15 (301 early stage) (hormone (agglomerative weight tiredness/fatigue, Patients with Endocrine
(72 late stage) treatment) hierarchical gain, vaginal dryness Therapy, International
method) and decreased sexual Breast Cancer
interest  Study Group
Linear Analogue Scales
for patients with
endocrine treatment
Ridner, 64 Breast ANCOVA Cluster 1 Alteration in limb sensation, 52-Item symptom
2005 16 (lymphedema) loss of confidence in body, checklist,
decreased physical activity, 11-item Iowa
fatigue, psychological 11×3 short-form
distress   Center for Epidemiologic
Studies of Depression,
37-item Profile of Mood
States—Short FormFAN et al.
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the lack of consistency in methodology between the
studies that have been done. Once symptom cluster
research is more developed, further research to find
predictors of firmly established symptom clusters can
be explored.
4. DISCUSSION
Symptom cluster research is in its early stages, and
many questions remain unanswered in this field. Be-
cause the research thus far is limited, it is too early to
confirm or deny the existence of common symptom
clusters in cancer patients.
Some publications on symptom clusters have in-
volved the symptoms depression, pain, sleep distur-
bance, and fatigue, but many of those studies did not
statistically test to validate the symptom cluster 19–21;
instead, the symptom clusters in those studies were
derived based on prior knowledge and literature about
the relationships between the chosen symptoms. As
interest in symptom clusters begins to expand, it will
be important to clearly define “symptom cluster” and
to reach consensus on a methodology for data col-
lection and analysis in symptom cluster research.
The literature search in the present review clearly
shows disparities in the methodology for symptom
cluster research. Symptom definitions, assessment
tools, and statistical methods varied widely in the
articles reviewed. Symptoms are subjective by na-
ture, involve multiple dimensions, and are most often
rated by the patient. Barsevick et al. 22 suggested that,
because of the compound quality of symptoms, mea-
suring only one dimension of a symptom would be a
practical approach. In addition, they suggested that
the ideal measure of symptom clusters would be con-
sistent in the response scaling of the symptoms and
in the measurement of parallel dimensions of each
symptom within the same time period and clinical
setting, and would implicate a reasonable response
burden to the patient 22. These propositions are prac-
tical and can serve as useful guidelines in the design
of symptom cluster research.
Still, it remains unclear when symptoms should
be considered valid for analysis. Miaskowski et al. 23
delineated this issue and asked whether a specific cut-
off score in symptom severity is warranted or whether
the presence or absence of the symptom suffices in
symptom cluster analysis. The answer to this ques-
tion first requires consideration of the statistical
method that is most compatible with the assessment
tools used to discover indications of symptom
clusters.
To maintain consistency of analysis in symptom
cluster research, a single statistical method should
be used. Researchers have used several statistical
methods to derive symptom clusters, including fac-
tor analysis and cluster analysis. In the present re-
view, two individual studies and the MDASI validation
studies used factor analysis (principal component
analysis with rotation), one individual study used
factor analysis without rotation, three studies used
cluster analysis, and one study used analysis of
covariance.
Different methods may yield different sets of clus-
ters, and results may vary depending on the statisti-
cal analysis technique used. Factor analysis examines
the relationships between variables such as symptom
severity and can make use of principal component
analysis to explain covariance and test for group dif-
ferences 22,24. On the other hand, cluster analysis is
used to find groups of individuals with similar symp-
tom profiles; it groups people instead of factors 22.
No work has yet been done to determine the most
suitable approach for finding symptom clusters; how-
ever, it is important for researchers to begin both to
refine and to define the statistical method used in
symptom cluster work.
The next step would be to select the assessment
tools appropriate for data collection. Seven of the
reported studies used 13 different symptom assess-
ment tools; almost every study used a unique ques-
tionnaire. Because the analysis is based on the
symptoms and scaling used in the assessment tools,
it is important that similar assessment tools be used
in all symptom cluster research. An 11-item ques-
tionnaire will produce results different from those
originating with a 32-item symptom inventory. Al-
though different populations may require slightly dif-
ferent questionnaires, a basic symptom inventory
with a sufficient sample of symptoms applicable to
all cancer patients should be applied in symptom
cluster research to ensure consistent data analysis.
Otherwise, the symptom clusters derived will vary
depending on the symptoms listed in the assessment
tools.
Symptom research will remain a complicated
topic because of the many confounding factors in the
symptom experience. Symptoms can be caused by
the disease, the treatment, or even the comorbidities,
and isolating the cause of each symptom is difficult.
However, the exploration of symptoms within vari-
ous demographic categories remains important. Once
symptom cluster research has been refined, it will be
useful to extract differences in symptom clusters by
age, sex, cancer type, disease stage, and ethnicity.
Moreover, further work in defining the length of
time that symptoms occur together before they are
considered a symptom cluster may be necessary, as
suggested by Barsevick 22. This distinction may be
difficult, because symptom clusters may evolve with
the deterioration that occurs as cancer progresses.
Nevertheless, the question is valid and necessary in
investigating symptom clusters.
Symptom research and the definition of symp-
tom clusters in the oncology population will revolu-
tionize treatment and diagnosis. The discovery of
validated symptom clusters will aid diagnostic crite-
ria, assessment, management, and prioritization ofSYMPTOM CLUSTERS IN CANCER PATIENTS
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care. Many papers have confirmed the prognostic
effect of multiple symptoms and the effect of those
symptoms on quality of life and functional status 16,25–29.
Thus the study of symptom clusters has important
implications in treatment strategy and understanding
of cancer.
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